Further, the onset of DM and IGT is characterized by insulin resistance, hyperinsulinemia, insulin stimulation of IGF-I production in the liver through the upregulated GH signaling pathway (e.g., upregulated expression of the hepatic GH receptor), and decreased IGFBP-1 level [3,  33]. The gene discussed is GH1; the disease is hyperinsulinism.